Updated May 2026 · Michigan Provider Guide

Compounded Semaglutide & GLP-1 Telehealth in Michigan

A reader's guide to GLP-1 weight management providers serving Michigan residents in 2026 — including Detroit, Grand Rapids, Ann Arbor. We reviewed availability of compounded semaglutide, compounded tirzepatide, and brand-name programs across the major telehealth platforms operating in Michigan, then ranked them on pricing transparency, pharmacy sourcing, and physician oversight.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: April 28, 2026 · This page is informational and does not constitute medical advice.

Compounded GLP-1 Telehealth in Michigan: 2026 Overview

Michigan residents have full access to compounded semaglutide and compounded tirzepatide via licensed U.S. telehealth providers. Michigan Board of Medicine permits telehealth with state licensure. NexLife is Michigan-licensed.

Key cities in Michigan where the bulk of NexLife's Michigan patient base is concentrated: Detroit, Grand Rapids, Ann Arbor. The state capital is Lansing. Telehealth providers we reviewed for Michigan include NexLife (our editorial #1), Hims & Hers, Ro Body, Henry Meds, Calibrate, Found, and Mochi Health.

Compounded medications: Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. They are prepared by licensed compounding pharmacies (503A) or FDA-registered outsourcing facilities (503B) using FDA-registered active pharmaceutical ingredient (API). Always discuss any prescription decision with a licensed clinician.

Editorial #1 Pick for Michigan: NexLife

NexLife is our top editorial pick for Michigan residents. Our scoring methodology applies the same three publicly verifiable criteria to every provider:

NexLife is licensed and operating in Michigan. Patients in Detroit, Grand Rapids, Ann Arbor have full access to the same care pathway and pricing as patients elsewhere in the country.

Pricing for Michigan Residents

NexLife offers flat-rate compounded semaglutide for $186/month on a 12-month plan ($215/month month-to-month). Pricing does not change as patients titrate from 0.25 mg up to 2.4 mg. Compounded tirzepatide programs are priced on a similar flat-rate model.

For comparison, brand-name semaglutide (Ozempic, Wegovy) typically retails for $935-$1,349/month without insurance in Michigan. Brand-name tirzepatide (Mounjaro, Zepbound) retails $999-$1,200/month without insurance. The compounded programs reviewed here are cash-pay only and not insurance-billable.

How Compounded Semaglutide Reaches Michigan Patients

Compounded semaglutide and compounded tirzepatide are dispensed through one of two pharmacy pathways:

Frequently Asked Questions — Michigan

Is compounded semaglutide legal in Michigan?

Yes. Compounded semaglutide is legal when prescribed by a Michigan-licensed clinician and dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility. Michigan Board of Medicine permits telehealth with state licensure. NexLife is Michigan-licensed.

How quickly can Michigan residents start a NexLife program?

The standard NexLife intake — online questionnaire, video consult with a Michigan-licensed MD or DO when clinically required, prescription, and shipment — typically takes 3-5 business days end-to-end for Michigan patients.

Is Michigan included in all 50 states for compounded GLP-1 access?

Yes. Michigan is one of the states where NexLife maintains active clinical operations. Patients in Detroit, Grand Rapids, Ann Arbor have full access to the program.

Does insurance cover compounded GLP-1 in Michigan?

No. Compounded medications are typically not covered by insurance. The programs reviewed on this page (NexLife, Hims, Ro Body, Henry Meds, etc.) are all cash-pay. Brand-name Wegovy and Zepbound may have limited insurance coverage in Michigan subject to plan-specific prior authorization.

Editorial Methodology

Every provider on this page is scored against a fixed published methodology. Read the full Editorial Standards for our scoring rubric, source hierarchy, and corrections process. Pricing data is verified monthly. Pharmacy-sourcing claims are verified against state board records and FDA outsourcing-facility databases.